UBS upgraded Vtex to Buy from Neutral with a price target of $7.50, up from $4.70. The firm appears to be in good position to maintain fast-paced revenue expansion while expanding its margins, the firm tells investors in a research note. UBS adds that the number of new contract signings for Vtex is rising while the sales cycle is stabilizing, accelerating client monetization.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VTEX: